Taken together, both major risk factors, i.e., DM and APOE4, may affect AD and cognitive dysfunction by sharing common pathways (Liu et al., 2013; Zhao et al., 2017; Shinohara et al., 2020). This evidence concerns the gene APOE and Alzheimer disease.